Search

Search Constraints

You searched for: Author/Creator Hans, Sophie

Search Results

1. Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. Issue 8 (6th June 2022)

2. Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database. (January 2020)

3. Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153–163]. (September 2020)

4. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020)

5. High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy. (December 2022)

6. Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study. (October 2021)